Mandibular Full-arch Rehabilitation With Internal Hexagonal and Conical Connection Implants
Primary Purpose
Edentulous Jaw
Status
Active
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Mandibular partial rehabilitation with IF Tapared implants
Mandibular partial rehabilitation with CF Tapared implants
Sponsored by
About this trial
This is an interventional treatment trial for Edentulous Jaw focused on measuring dental implants, oral rehabilitation
Eligibility Criteria
Inclusion Criteria:
Patients who qualify for mandibular rehabilitation by means of full-arch prostheses supported by two Nuvo Tapered IF implants and two Tapered CF implants
Exclusion Criteria:
Contraindications according to the Instructions for Use of the device will be applied, as follows:
- Signs of allergy or hypersensitivity to the chemical ingredients of the material: titanium;
- Presence of acute inflammatory or infectious processes in live tissue;
- Unsuitable bone volume and/or quality;
- Systemic complications or diseases such as: bone metabolism disorders, blood clotting disorders, unsuitable healing capacity, insufficient oral hygiene, incomplete jawbone growth, patient uncooperative and not motivated, abuse of drugs or alcohol, psychosis, prolonged functional disorders which resist any treatment with medications, xerostomia, weakened immunological system, diseases which require the use of steroids, endocrinological diseases, pregnancy.
The research does not involve minors, or women who are pregnant or breastfeeding.
Sites / Locations
- Mattias Sartori Consultoria Em Odontologia
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Group IF
Group CF
Arm Description
Two Tapered IF implants will be installed in one side of the mandible
Two Tapered IF implants will be installed in the other side of the mandible
Outcomes
Primary Outcome Measures
Periimplant bone level change
Amount of Periimplant bone level change 36 months after loading.
Secondary Outcome Measures
Implant survival rate
Survival will be defined as no loss of the implant at each follow-up
Prosthetic survival
Prosthetic survival will be assessed as the final prosthesis remaining in situ at each follow-up.
Soft tissue evaluation
visible plaque index, maginal bleeding index, bleeding on probing, gingival index, keratinized tissue height measurements
Patient satisfaction
The Portuguese translation of OHIP-EDENT questionnaire will be used to assess Oral Health Related Quality of Life (OHRQoL), as a measure of patient satisfaction with treatment.
Clinician satisfaction
The assessment will be performed by means of a questionnaire using a visual analog scale (VAS) in the form of a 10 cm horizontal line, where 0 (left end) indicates minimum satisfaction and 10 (right end) indicates maximum satisfaction
Adverse events
Determined by inquiring with the patient and clinical evaluation
Device deficiences
Determined by inquiring with the patient and clinical evaluation
Implant success rate
Absence of persisting subjective discomfort such as pain, foreign body perception and or dysaesthesia (painful sensation);
Absence of a recurrent periimplant infection with suppuration (infection is termed recurrent if observed at two or more follow-up visits after the treatment with systemic antibiotics);
Absence of implant mobility on manual palpation;
Absence of any continuous periimplant radiolucency.
Prosthetic success rate
Success will be defined as the prosthesis that remained unchanged and did not require any intervention
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05082038
Brief Title
Mandibular Full-arch Rehabilitation With Internal Hexagonal and Conical Connection Implants
Official Title
Mandibular Full-arch Rehabilitation With Internal Hexagonal and Conical Connection Implants: Randomized Split-mouth Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
September 23, 2021 (Actual)
Primary Completion Date
May 1, 2025 (Anticipated)
Study Completion Date
July 30, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Neodent
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Nuvo Tapered IF (internal hexagonal connection) and CF (conical connextion) Implants were designed for the the oral functional rehabilitation using dental implants, allowing for treatment of patients with different bone qualities.
The aim of the study is to confirm the long-term safety and clinical performance of implants and abutments of Nuvo IF and CF in daily dental practice setting, by means of prospective collection of clinical data in randomized clinical trial using these devices.
Devices will be used , according to manufacturer indications in the IFU. Patients will be followed for 36 months after implant loading.
Detailed Description
The study protocol was reviewed and approved by an Ethics Committee (CE) in Brazil. The sample will be prospectively selected and will consist of 18 patients, presenting 18 years of age or more, complete edentulism, who qualify for mandibular rehabilitation by means of full-arch prostheses supported by two Nuvo Tapered IF implants and two Tapered CF implants .Informed consent in writing will be obtained from each patient participating in the study prior to any study related procedure.
Before study site activation, the implants of each patient in the study will be randomly allocated (allocation ratio 1:1), so that each patient receives two implants from each group, on each side of the mandibular arch (Group IF: Tapered Implants with internal hexagonal connection; Group CF: Tapered Implants with conical connection). A blocked randomization list will be generated, where the sequence within block corresponds to the quadrant each group of implants shall be inserted (1:right quadrant; 2: left quadrant). The Randomization List will be kept by the Sponsor in the Trial Master File. Although this study is not blinded, access to the randomization list will not be available to the study centers or to the subjects.
Treatment provided to the subjects will be the responsibility of an appropriately qualified dental practitioners (principal investigator and coinvestigator) to provide the relevant patient care under clinical study conditions, In the mandible, four implants will be placed under local anesthesia and with adequate bone bed preparation, as recommended by the manufacturer, being two Tapered IF implants on one side and two Tapered CF implants on the other, according to the established by the randomization results. The implants will be placed at preferably in an axial position for the medial implants and distally angled for the distal ones, depending on bone availability.
Immediately after implant placement, the final insertion torque shall be recorded. The selection of the prosthetic component and loading protocol (late or immediate) shall be conducted according to the need of each subject and to the manufacturer's instructions (IFU). Thus, implant immediate loading may be performed (at the discretion of the surgeon) when all implants present primary stability of at least 35 N.cm. Maxillary rehabilitation will be performed by means of confection of muco-supported dentures.
Data concerning the studied variables (mandibular rehabilitation) will be collected following the procedures and assessments plan by fulfilling the Case Report Form (CRF), in the following stages: First visit (Screening); TP - Implants placement; T0 - Implant loading; T6, T12, T24 and T36 - 6, 12, 24 and 36 months, respectively, thereafter.
Panoramic radiographs, lateral cephalometric radiographs and computed tomography (CT) scans will be obtained from the region of interest prior to surgery, for the surgical planning. Additionally, standardized digital periapical radiographs will be taken in a usual daily practice frequency, as determined by the investigator: after implants placement (TP - immediately or within 1 week after implant placement) and during the post-operative stages (T0, T6, T12, T24 and T36) to assess the osseointegration process, changes in peri-implant bone level as well as prosthetic settlement and integrity.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Edentulous Jaw
Keywords
dental implants, oral rehabilitation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
18 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group IF
Arm Type
Other
Arm Description
Two Tapered IF implants will be installed in one side of the mandible
Arm Title
Group CF
Arm Type
Other
Arm Description
Two Tapered IF implants will be installed in the other side of the mandible
Intervention Type
Device
Intervention Name(s)
Mandibular partial rehabilitation with IF Tapared implants
Intervention Description
2 IF Tapared Implants (Group IF) on one side of the mandible
Intervention Type
Device
Intervention Name(s)
Mandibular partial rehabilitation with CF Tapared implants
Intervention Description
2 CF Tapared Implants (Group CF) on the other side of the mandible
Primary Outcome Measure Information:
Title
Periimplant bone level change
Description
Amount of Periimplant bone level change 36 months after loading.
Time Frame
up to 36 months
Secondary Outcome Measure Information:
Title
Implant survival rate
Description
Survival will be defined as no loss of the implant at each follow-up
Time Frame
up to 36 months
Title
Prosthetic survival
Description
Prosthetic survival will be assessed as the final prosthesis remaining in situ at each follow-up.
Time Frame
6, 12, 24 and 36 months
Title
Soft tissue evaluation
Description
visible plaque index, maginal bleeding index, bleeding on probing, gingival index, keratinized tissue height measurements
Time Frame
up to 36 months
Title
Patient satisfaction
Description
The Portuguese translation of OHIP-EDENT questionnaire will be used to assess Oral Health Related Quality of Life (OHRQoL), as a measure of patient satisfaction with treatment.
Time Frame
up to 36 months
Title
Clinician satisfaction
Description
The assessment will be performed by means of a questionnaire using a visual analog scale (VAS) in the form of a 10 cm horizontal line, where 0 (left end) indicates minimum satisfaction and 10 (right end) indicates maximum satisfaction
Time Frame
up to 36 months
Title
Adverse events
Description
Determined by inquiring with the patient and clinical evaluation
Time Frame
up to 36 months
Title
Device deficiences
Description
Determined by inquiring with the patient and clinical evaluation
Time Frame
up to 36 months
Title
Implant success rate
Description
Absence of persisting subjective discomfort such as pain, foreign body perception and or dysaesthesia (painful sensation);
Absence of a recurrent periimplant infection with suppuration (infection is termed recurrent if observed at two or more follow-up visits after the treatment with systemic antibiotics);
Absence of implant mobility on manual palpation;
Absence of any continuous periimplant radiolucency.
Time Frame
up to 36 months
Title
Prosthetic success rate
Description
Success will be defined as the prosthesis that remained unchanged and did not require any intervention
Time Frame
up to 36 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patients who qualify for mandibular rehabilitation by means of full-arch prostheses supported by two Nuvo Tapered IF implants and two Tapered CF implants
Exclusion Criteria:
Contraindications according to the Instructions for Use of the device will be applied, as follows:
Signs of allergy or hypersensitivity to the chemical ingredients of the material: titanium;
Presence of acute inflammatory or infectious processes in live tissue;
Unsuitable bone volume and/or quality;
Systemic complications or diseases such as: bone metabolism disorders, blood clotting disorders, unsuitable healing capacity, insufficient oral hygiene, incomplete jawbone growth, patient uncooperative and not motivated, abuse of drugs or alcohol, psychosis, prolonged functional disorders which resist any treatment with medications, xerostomia, weakened immunological system, diseases which require the use of steroids, endocrinological diseases, pregnancy.
The research does not involve minors, or women who are pregnant or breastfeeding.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Waleska Caldas, PhD
Organizational Affiliation
Neodent
Official's Role
Study Chair
Facility Information:
Facility Name
Mattias Sartori Consultoria Em Odontologia
City
Bauru
State/Province
São Paulo
Country
Brazil
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Mandibular Full-arch Rehabilitation With Internal Hexagonal and Conical Connection Implants
We'll reach out to this number within 24 hrs